Document is current
Any future updates will be listed below
-
Authors
King, Ben https://orcid.org/0000-0001-8248-5547
Milling, Truman
Gajewski, Byron
Costantini, Todd W
Wick, Jo
Price, Michelle A https://orcid.org/0000-0001-6402-7956
Mudaranthakam, Dinesh
Stein, Deborah M
Connolly, Stuart
Valadka, Alex
Warach, Steven
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03153150 at ClinicalTrials.govnct03968393 at ClinicalTrials.govDocuments that mention this clinical trial
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials
https://doi.org/10.1136/tsaco-2020-000605
Anticoagulant in atrial fibrillation patients with prior intracranial haemorrhage: a meta-analysis
https://doi.org/10.1136/heartjnl-2023-322492
nct03186729 at ClinicalTrials.govDocuments that mention this clinical trial
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials
https://doi.org/10.1136/tsaco-2020-000605
nct03243175 at ClinicalTrials.govDocuments that mention this clinical trial
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials
https://doi.org/10.1136/tsaco-2020-000605
Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges
https://doi.org/10.1136/jnnp-2020-325249
nct02565693 at ClinicalTrials.govDocuments that mention this clinical trial
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials
https://doi.org/10.1136/tsaco-2020-000605
nct03950076 at ClinicalTrials.govDocuments that mention this clinical trial
In patients with intracerebral haemorrhage and concomitant atrial fibrillation, optimal timing of reinitiating anticoagulants may be 7–8 weeks after ICH
https://doi.org/10.1136/ebmed-2017-110675
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials
https://doi.org/10.1136/tsaco-2020-000605
nct04229758 at ClinicalTrials.govDocuments that mention this clinical trial
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials
https://doi.org/10.1136/tsaco-2020-000605
Anticoagulation after intracerebral haemorrhage: clarity or confusion?
https://doi.org/10.1136/jnnp-2025-336803
Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials
https://doi.org/10.1136/jnnp-2025-336169
Documents that mention this clinical trial
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials
https://doi.org/10.1136/tsaco-2020-000605
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (1K23HL127227-01A1)
- License Information
